The New York Entrepreneur

Kenvue earnings top estimates in J&J spinoff’s first quarterly report since IPO

Read Time:8 Second

J&J still owns a 90% stake in Kenvue, meaning it can generally control the direction of the consumer health spinoff’s business for the time being.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post American Airlines raises 2023 profit forecast after strong second quarter
Next post Crypto price prediction: Arkham (ARKM) and AltSignals (ASI)